Psychophysiological Aspects of Tourette's Syndrome

Journal of Psychology: Interdisciplinary and Applied

Volumn 131, Issue 6, 1997, Pages 615-626

  Murray, John B ^a  

^a ST JOHN'S UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; HALOPERIDOL;

ADOLESCENT; ADULT; BRAIN; CHILD; DRUG EFFECT; FEMALE; GENETICS; GILLES DE LA TOURETTE SYNDROME; HEMISPHERIC DOMINANCE; HUMAN; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; PSYCHOLOGICAL ASPECT; REVIEW; SOCIAL ADAPTATION;

ADOLESCENT; ADULT; BRAIN; CHILD; CHILD, PRESCHOOL; DOMINANCE, CEREBRAL; FEMALE; HALOPERIDOL; HUMANS; MALE; NEUROTRANSMITTER AGENTS; SOCIAL ADJUSTMENT; TOURETTE SYNDROME;

EID: 0031265256     PISSN: 00223980     EISSN: None     Source Type: Journal    
DOI: 10.1080/00223989709603843     Document Type: Article

References (87)

1. Azrin, N. H., & Peterson, A. L. (1988). Habit reversal for the treatment of Tourette syndrome. Behaviour Research and Therapy, 26, 347-351.
2. Barabas, G. (1988). Tourette's syndrome: An overview. Psychiatric Annals, 18, 393-398.
3. Bornstein, R. A., King, G., & Carroll, A. (1983). Neuropsychological abnormalities in Gilles de la Tourette's syndrome. Journal of Nervous and Mental Disease, 171, 497-501.
4. Braun, A., Mouradian, M. M., Mohr, E., Fabbrini, G., & Chase, T. M. (1989). Selective D-1 dopamine receptor agonist effects in hyperkinetic extrapyramidal disorders. Journal of Neurology, Neurosurgery, & Psychiatry, 52, 631-635.
5. Bruun, R. D. (1984). Gilles de la Tourette's syndrome: An overview of clinical experience. Journal of American Academy of Child Psychiatry, 23, 126-133.
6. Bruun, R. D. (1988). Subtle and underrecognized side effects of neuroleptic treatment in children with Tourette's disorder. American Journal of Psychiatry, 145, 621-624.
7. Burd, L., Fisher, W. W., Kerbeshian, U., & Arnold, M. F. (1987). Is development of Tourette disorder a marker for improvement with autism and other pervasive developmental disorders? Journal of American Academy of Child and Adolescent Psychiatry, 26, 162-165.
8. Campbell, M., & Cueva, J. E. (1995). Psychopharmacology in child and adolescent psychiatry: A review of the past seven years. Part II. Journal of American Academy of Child and Adolescent Psychiatry, 34, 1262-1272.
9. Chappell, P., Riddle, M., Anderson, G., Scahill, L., Hardin, M., Walker, D., Cohen, D., & Leckman, J. (1994). Enhanced stress responsivity of Tourette's syndrome patients undergoing lumbar puncture. Biological Psychiatry, 36, 35-43.
10. Cohen, A. J., & Leckman, J. F. (1992). Sensory phenomena associated with Gilles de la Tourette's syndrome. Journal of Clinical Psychiatry, 53, 319-323.
11. Cohen, D. J., Detlor, J., Young, J. G., & Shaywitz, B. A. (1980). Clonidine ameliorates Gilles de la Tourette syndrome. Archives of General Psychiatry, 37, 1350-1357.
12. Cohen, D. J., Riddle, W. A., & Leckman, J. F. (1992). Pharmacotherapy of Tourette's syndrome and associated disorders. Psychiatric Clinics of North American, 15(1), 109-129.
13. Cohen, D. J., Shaywitz, B. A., Caparulo, B., Young, G., & Bowers, W. B., Jr. (1978). Chronic, multiple tics of Gilles de la Tourette's disease. Archives of General Psychiatry, 35, 245-250.
14. Comings, D. E. (1987). A controlled study of Tourette syndrome VII. Summary: A common genetic disorder causing disinhibition of the limbic system. American Journal of Human Genetics, 41, 839-866.
15. Eapen, V., Moriarty, J., & Robertson, M. M. (1994). Stimulus induced behaviors in Tourette's syndrome. Journal of Neurology, Neurosurgery, and Psychiatry, 57, 853-855.
16. Eapen, V., Pauls, , & Robertson, M. M. (1993). Evidence for autosomal dominant transmission in Tourette's syndrome United Kingdom cohort study. British Journal of Psychiatry, 162, 593-596.
17. Eapen, V., & Robertson, M. M. (1994). All that tics may not be Tourette's (letter to editor). British Journal of Psychiatry, 164, 708.
18. Eapen, V., & Srinath, S. (1982). Gilles de la Tourette syndrome in India: Two cases. Psychological Reports, 70, 667-668.
19. Erenberg, G. (1988). Pharmacologic therapy of tics in childhood. Psychiatric Annals, 18, 399-408.
20. Feinberg, M., & Carroll, B. J. (1979). Effects of dopamine agonists and antagonists in Tourette's disease. Archives of General Psychiatry, 36, 979-985.
21. Fennig, S., Fennig, S. N., Pato, M., & Weitzman, A. (1994). Emergence of symptoms of Tourette's syndrome during fluvoxamine treatment of obsessive compulsive disorders. British Journal of Psychiatry, 164, 839-841.
22. Fisher, W., Burd, L., Conlon, C., & Conlon, R. (1986). Educating children and adults on coping with Tourette's syndrome. Perceptual and Motor Skills, 62, 530.
23. Frank, M. S., Sieg, K. G., & Gaffney, G. R. (1991). Somatic complaints in childhood tic disorders. Psychosomatics, 32, 396-399.
24. Frankel, M., Cummings, J. L., Robertson, M. M., Trimble, M. R., Hill, M. A., & Benson, D. F. (1986). Obsessions and compulsions in Gilles de la Tourette's syndrome. Neurology, 36, 378-382.
25. George, M. S., Robertson, M. M., Costa, D. C., Ell, P. J., Trimble, M. R., Pilowsky, L., & Verhoeff, N. P. L. G. (1994). Dopamine receptor availability in Tourette's syndrome. Psychiatry Research, 55, 193-202.
26. George, M. S., Trimble, M. R., King, H. A., Sallee, F. R., & Robertson, M. M. (1993). Obsessions in obsessive-compulsive disorder with and without Gilles de la Tourette's disorder. American Journal of Psychiatry, 150, 93-97.
27. Goetz, C. G., Tanner, C. M., Stebbins, G. T., Leipzig, G., & Carr, W. C. (1992). Adult tics in Gilles de la Tourette's syndrome: Description and risk factor. Neurology, 42, 784-788.
28. Goetz, C. G., Tanner, C. M., Wilson, R. S., & Shannon, K. M. (1987). A rating scale for Gilles de la Tourette's syndrome: Description, reliability, and validity data. Neurology, 37, 1542-1544.
29. Golden, G. S. (1988). The relationship between stimulant medication and tics. Psychiatric Annals, 18, 409-413.
30. Hyde, T. M., Emsellen, H. A., Randolph, C., Rickler, K. C., & Weinberger, D. R. (1994). Electroencephalic abnormalities in monozygotic twins with Tourette's syndrome. British Journal of Psychiatry, 164, 811-817.
31. Jagger, J., Prusolff, B. A., Cohen, D. J., Kidd, K. K., Carbonari, C. M., & John, K. (1982). The epidemiology of Tourette's syndrome: A pilot study. Schizophrenia Bulletin, 8, 267-278.
32. Kane, M. J. (1994). Premonitory urges as "attentional tics" in Tourette's syndrome. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 805-808.
33. Kerbeshian, J., Burd, L., & Klug, M. G. (1995). Comorbid Tourette's disorder and bipolar disorder: An etiologic perspective. American Journal of Psychiatry, 152, 1646-1651.
34. Kohen, D. P., & Botts, P. (1987). Relaxation therapy (self-hypnosis) in Tourette's syndrome: Experience with four children. American Journal of Hypnosis, 29, 227-237.
35. Kurlan, R. (1989). Tourette's syndrome: Current concepts. Neurology, 39, 1625-1630.
36. Kurlan, R., Behr, J., Medved, L., Shoulson, I., Pauls, D., Kidd, J. R., & Kidd, K. K. (1986). Familial Tourette's syndrome: Report of a large pedigree and potential for linkage analysis. Neurology, 36, 772-776.
37. Kurlan, R., Whitmore, D., Irvine, C., McDermott, M. P., & Como, P. G. (1994). Tourette's syndrome in a special education population. Neurology, 44, 696-702.
38. Lang, A. (1991). Patient perception of tics and other movement disorders. Neurology, 41, 223-228.
39. Lanser, J. B. K., Van Santen, W. H. C., Jennekens-Schinkel, A., & Roos, R. A. C. (1993). Tourette's syndrome and right hemisphere dysfunction. British Journal of Psychiatry, 163, 116-118.
40. Lapin, E. P., Maker, H. S., Sershen, H., Hurd, Y., & Lajtha, A. (1987). Dopamine-like action of nicotine: Lack of tolerance and reverse tolerance. Brain Research, 407, 351-363.
41. Leckman, J. F., Detlor, J., Harcherik, D. F., Ort, S., Shaywitz, B. A., & Cohen, D. J. (1985). Short- and long-term treatment of Tourette's syndrome with clonidine: A clinical perspective. Neurology, 35, 343-345.
42. Leckman, J. F., Detlor, J., Harcherik, D. F., Young, J. G., Anderson, G. M., Shaywitz, B. A., & Cohen, D. J. (1983). Acute and chronic clonidine treatment in Tourette's syndrome: A preliminary report on clinical response and effect on plasma and urinary catecholamine metabolites, growth hormone, and blood pressure. Journal of American Academy of Child Psychiatry, 22, 433-440.
43. Leckman, J. F., Dolansky, E. S., Hardin, M. T., Clubb, M., Walkup, J. T., Stevenson, J., & Pauls, D. L. (1990). Perinatal factors in the expression of Tourette's syndrome: An exploratory study. Journal of American Academy of Child and Adolescent Psychiatry, 29, 220-226.
44. Leckman, J. F., Goodman, W. K., North, W. G., Chappell, P. B., Price, L. H., Pauls, D. L., Anderson, G. W., Riddle, M. A., McSwiggan-Hardin, M., McDougle, C. J., Barr, L. C., & Cohen, D. J. (1994). Elevated cerebrospinal fluid levels of oxytocin in obsessive compulsive disorder: Comparison with Tourette's syndrome. Archives of General Psychiatry, 51, 782-792.
45. Leckman, J. F., Hardin, M. T., Riddle, M. A., Stevenson, J., Ort, S. I., & Cohen, D. J. (1991). Clonidine treatment of Gilles de la Tourette's syndrome. Archives of General Psychiatry, 48, 324-328.
46. Leckman, J. F., Riddle, M. A., Berrettini, W. H., Anderson, G. M., Hardin, M. T., Chappell, P., Bissette, G., Nemeroff, C. B., Goodman, W. K., & Cohen, D. J. (1988). Elevated CSF dynorphin A (1-8) in Tourette's syndrome. Life Sciences, 43, 2015-2023.
47. Leckman, J. F., Walker, D. E., & Cohen, D. J. (1983). Premonitory urges in Tourette's syndrome. Life Sciences, 43, 2015-2023.
48. Leonard, H. L., Lenane, M. G., Swedo, S. E., Rettow, D. C. Gershon, E. S., & Rapoport, J. L. (1992). Tics and Tourette's disorder. A 2-to 7-year follow-up of 54 obsessive-compulsive children. American Journal of Psychiatry, 149, 1244-1251.
49. Lowe, T. L., Cohen, D. J., Detlor, J., Kremenitzer, M. W., & Shaywitz, B. A. (1982). Stimulant medications precipitate Tourette's syndrome. Journal of American Medical Association, 247, 1729-1731.
50. Matthews, W. S. (1988). Attention deficit and learning disabilities in children with Tourette's syndrome. Psychiatric Annals, 18, 414-416.
51. McConville, B. J., Fogelson, M. H., Norman, A. B., Klykylo, W. M., Manderscheid, P. Z., Parker, K. W., & Sanberg, P. R. (1991). Nicotine potentiation of haloperidol in reducing tic frequency in Tourette's disorder. American Journal of Psychiatry, 148, 793-794.
52. Mesulam, M. M. (1986). Cocaine use and Tourette's syndrome (letter to editor). New England Journal of Medicine, 315, 398.
53. Mesulam, M. M., & Petersen, R. C. (1987). Treatment of Gilles de la Tourette's syndrome: Eight-year practice-based experience in a predominantly adult population. Neurology, 37, 1828-1833.
54. Meuldijk, R., & Colon, E. J. (1992). Methadone treatment of Tourette's syndrome (letter to editor). American Journal of Psychiatry, 149, 139-140.
55. Moriarty, J., Costa, D. C., Schmitz, B., Trimble, M. R., Ell, P. J., & Robertson, M. M. (1995). Brain perfusion abnormalities in Gilles de la Tourette's syndrome. British Journal of Psychiatry, 167, 249-254.
56. Moss, D. E., Manderscheid, P. Z., Montgomery, S. P., Norman, A. B., & Sanberg, P. R. (1989). Nicotine and cannabinoids as adjuncts to neuroleptics in the treatment of Tourette's syndrome and other motor disorder. Life Sciences, 44, 1521-1525.
57. Ostfeld, B. M. (1988). Psychological intervention in Gilles de la Tourette's syndrome. Psychiatric Annals, 18, 417-420.
58. Ozonoff, S., Strayer, D. L., McMahon, W. M., & Filloux, F. (1994). Executive function abilities in autism and Tourette's syndrome: An information processing approach. Journal of Child Psychology and Psychiatry, 35, 1015-1032.
59. Park, S., Como, P. G., Cui, L., & Kurlan, R. (1993). The early course of the Tourette's syndrome clinical spectrum. Neurology, 43, 1712-1715.
60. Pauls, D. L., & Leckman, J. F. (1986). The inheritance of Gilles de la Tourette's syndrome and associated behaviors: Evidence for autosomal dominant transmission. New England Journal of Medicine, 315, 993-997.
61. Pauls, D. L., Leckman, J. F., & Cohen, D. F. (1993). Familial relationship between Gilles de la Tourette's syndrome, attention deficit disorder, learning disabilities, speech disorders, and stuttering. Journal of American Academy of Child and Adolescent Psychiatry, 32, 1044-1050.
62. Pauls, D. L., Leckman, J. F., & Cohen, D. F. (1994). Evidence against a genetic relationship between Tourette's syndrome and anxiety, depression, panic and phobic disorder. British Journal of Psychiatry, 164, 215-221.
63. Pauls, D. L., Towbin, K. E., Leckman, J. F., Zahner, G. E. P., & Cohen, D. J. (1986). Gilles de la Tourette's syndrome and obsessive-compulsive disorder. Archives of General Psychiatry, 43, 1180-1182.
64. Pennington, B. F., & Smith, S. D. (1988). Genetic influences on learning disabilities: An update. Journal of Consulting and Clinical Psychology, 56, 817-823.
65. Peterson, A. L., & Azrin, N. H. (1992). An evaluation of behavioral treatments for Tourette syndrome. Behaviour Research and Therapy, 30, 167-174.
66. Pitman, R. K., Green, R. C., Jenike, M. A., & Mesulam, M. M. (1987). Clinical comparison of Tourette's disorder and obsessive-compulsive disorder. American Journal of Psychiatry, 144, 1166-1171.
67. Riddle, M. A., Hardin, M. T., King, R., Scahill, L., & Woolston, J. L. (1990). Fluoxetine treatment of children and adolescents with Tourette's and obsessive-compulsive disorders: Preliminary clinical experience. Journal of American Academy of Child and Adolescent Psychiatry, 29, 45-8.
68. Riddle, M. A., Leckman, J. R. Anderson, G. M., Ort, S. I., Hardin, M. T., Stevenson, J., & Cohen, D. J. (1988). Tourette's syndrome: Clinical and neurochemical correlates. Journal of American Academy of Child and Adolescent Psychiatry, 27, 409-412.
69. Robertson, M. M. (1989). The Gilles de la Tourette syndrome: the current status. British Journal of Psychiatry, 154, 147-169.
70. Robertson, M. M. (1994). Annotation: Gilles de la Tourette syndrome - An update. Journal of Child Psychology and Psychiatry, 35, 597-611.
71. Robertson, M. M., Channon, S., Baker, J., & Flynn, D. (1993). The psychopathology of Gilles de la Tourette's syndrome: A controlled study. British Journal of Psychiatry, 162, 114-117.
72. Robertson, M. M., & Gourdie, A. (1990). Familial Tourette's syndrome in a large British pedigree associated psychopathology, severity, and potential linkage analysis. British Journal of Psychiatry, 156, 515-521.
73. Robertson, M. M., Schmieden, V., & Lees, A. J. (1990). Management of Gilles de la Tourette syndrome using sulpuride. Clinical Neuropharmacology, 13, 229-235.
74. Robertson, M. M., Trimble, M. R., & Lees, A. J. (1988). The psychopathology of the Gilles de la Tourette syndrome: A phenomenological analysis. British Journal of Psychiatry, 152, 383-390.
75. Sanberg, P. R., Fogelson, H. M., Manderscheid, P. Z., Parker, K. W., Norman, A. B., & McConville, B. J. (1988). Nicotine gum and haloperidol in Tourette's syndrome (letter to editor). Lancet, 1, 592.
76. Shapiro, A. K., & Shapiro, E. (1984). Controlled study of pimozide vs. placebo in Tourette's syndrome. Journal of American Academy of Child Psychiatry, 23, 161-173.
77. Shapiro, A. KL., Shapiro, E., & Eisenkraft, G. J. (1983). Treatment of Gilles de la Tourette's syndrome with clonidine and neuroleptics. Archives of General Psychiatry, 40, 1235-1240.
78. Shapiro, A. K., Shapiro, E., Wayne, H., & Clarkin, J. (1973). Organic factors in Gilles de la Tourette's syndrome. British Journal of Psychiatry, 122, 659-664.
79. Shapiro, E., Shapiro, A. K., Fulop, G., Hubbard, M., Mandeli, J., Nordlie, J., & Phillips, R. A. (1989). Controlled study of haloperidol, pimozide, and placebo for the treatment of Gilles de la Tourette's syndrome. Archives of General Psychiatry, 46, 722-730.
80. Singer, H. S., Reiss, A. L., Brown, J. E., Aylward, E. H., Shih, B., Chee, E., Harris, E. L., Reader, M. J., Chase, G. A., Bryan, R. N., & Denckla, M. R. (1993). Volumetric MRI changes in basal ganglia of children with Tourette's syndrome. Neurology, 43, 950-956.
81. Smith, S. J. M., & Lees, A. J. (1989). Abnormalities of the blink reflex in Gilles de la Tourette syndrome. Journal of Neurology, Neurosurgery, and Psychiatry, 52, 895-898.
82. Stahl, S. M., & Berger, P. A. (1980). Cholinergic treatment in the Tourette syndrome (letter to editor). New England Journal of Medicine, 302, 1311.
83. Stefl, M. E. (1984). Mental health needs associated with Tourette syndrome. American Journal of Public Health, 74, 1310-1313.
84. Sverd, J., Gadow, K. D., & Paolicelli, L. M. (1989). Methylphenidate treatment of attention-deficit hyperactivity disorder in boys with Tourette's syndrome. Journal of American Academy of Child and Adolescent Psychiatry, 28, 574-579.
85. Tanner, C. M., Goetz, C. G., & Klawans, H. L. (1982). Cholinergic mechanisms in Tourette syndrome. Neurology, 32, 1315-1317.
86. Turjanski, N., Sawle, G. V., Playford, E. D., Weeks, R., Lammerstma, A. A., Lees, A. J., & Brooks, D. J. (1994). PET studies of presynaptic and postsynaptic dopaminergic system in Tourette's syndrome. Journal of Neurology, Neurosurgery, and Psychiatry, 57, 688-692.
87. Weizman, A., Mandel, A., Barber, Y., Weitz, R., Cohen, A., Mester, R., & Rehavi, M. (1992). Decreased platelet imipramine in Tourette syndrome children with obsessive-compulsive disorder. Biological Psychiatry, 31, 705-711.